mary claire haver glp 1 GLP-1s aren’t a shortcut. They’re a lifeline. https://podcasts.apple.com/us/podcast/unpaused-with-dr-mary-claire-haver/id1846701533?i=1000736237669, On this episode of unPAUSED, @drsalaswhalen and I Dr. Mary Claire Haver Joins

Accelerated Healing: BPC 157 has shown promise in promoting the healing of various tissues, including muscles, tendons, ligaments, and the gastrointestinal tract

Side effects and safety considerations Penta deca peptide arginate has demonstrated a favorable safety profile in preclinical research, with a wide therapeutic margin and low incidence of adverse effects

They avoid needles, can be administered easily at home, and are often better suited for regular daily use to support restorative sleep and better sleep quality over time

GLP-1 receptor agonists like semaglutide are increasingly covered for obesity and diabetes

In fact, the existing preclinical research shows the opposite

The final IPPS market basket percentage increase applicable to the OPD fee schedule for CY 2026 is 3.3 percent